Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

Every year there are > 33 million cases of Respiratory Syncytial Virus (RSV)-related respiratory infection in children under the age of five, making RSV the leading cause of lower respiratory tract infection (LRTI) in infants. RSV is a global infection, but 99% of related mortality is in low/midd...

Descripción completa

Detalles Bibliográficos
Autores principales: Efstathiou, C., Abidi, S. H., Harker, J., Stevenson, N. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298439/
https://www.ncbi.nlm.nih.gov/pubmed/32556372
http://dx.doi.org/10.1007/s00018-020-03557-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298439/
https://www.ncbi.nlm.nih.gov/pubmed/32556372
http://dx.doi.org/10.1007/s00018-020-03557-0

Ejemplares similares